Highly Active Antiretroviral Therapy (HAART) - “Sulfonyl”, and anal cancer outcomes from patients living with HIV: a retrospective cohort

Highly Active Antiretroviral Therapy (HAART) - “Sulfonyl”, and anal cancer outcomes from patients living with HIV: a retrospective cohort

Abstract Background Although anal cancer is a rare malignancy, its incidence is up to 30 times higher among individuals living with HIV. Recent evidence suggests that Highly Active Antiretroviral Therapy (HAART) regimens containing sulfonyl groups may exhibit antitumor properties. Based on these fin...

Full description

Saved in:
Bibliographic Details
Main Authors: Raelson Rodrigues Miranda, Erika Andrade Rocha, Amanda Acioli de Almeida Robatto, Denis Artico Galhera, Carolina Ribeiro Victor, Karim Yaqub Imbrahim, Camila Motta Venchiarutti Moniz
Format: Article
Language:English
Published: BMC 2025-08-01
Series:Infectious Agents and Cancer
Subjects:
Anal Cancer
HighlyActive Antiretroviral Therapy
HIV
Radiotherapy
Chemotherapy
Online Access:https://doi.org/10.1186/s13027-025-00666-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13027-025-00666-y

Similar Items